fda approvals in bladder cancer and hodgkin lymphoma, breakthrough designation in aml, and more
Published 8 years ago • 149 plays • Length 10:18
Download video MP4
Download video MP3
Similar videos
-
8:30
fda approvals in bladder cancer, nsclc, aml, hcc, and a breakthrough designation in nsclc
-
9:27
fda approval in bladder cancer, breakthrough therapy designation in dlbcl, and more
-
9:10
fda approvals in cml and hodgkin lymphoma, priority review in crc, and more
-
9:25
fda approvals in large b-cell lymphoma and melanoma, priority reviews in cscc and nsclc, and more
-
9:42
fda approval in lung cancer, promising findings in hodgkin lymphoma, and more
-
6:09
fda approvals in breast cancer and hodgkin lymphoma, 2017 sgo highlights, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
13:02
fda approvals in non-hodgkin lymphoma, breast cancer, gvhd, and mesothelioma
-
9:41
fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
-
7:11
review on 2016 fda approvals, halt on aml trials, and more
-
7:39
fda approvals in follicular lymphoma and gi, lung nets, snda in prostate cancer, and more
-
8:43
fda approvals in bladder cancer and nsclc, and 2019 elcc highlights
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
3:19
fda approval of durvalumab for advanced bladder cancer
-
11:32
fda approvals in breast cancer and nsclc, nda accepted in hcc, and more
-
2:03
durvalumab fda approval for bladder cancer
-
10:01
fda approvals in sclc and a biosimilar, and japanese approvals in aml, ntrk tumors, and more
-
13:36
fda approval in prostate cancer, nda submitted in cll and follicular lymphoma, and more
-
7:26
fda approval in ovarian cancer, priority reviews in nsclc, cll, and follicular lymphoma, and more
Clip.africa.com - Privacy-policy